5 ms·
That's what the article says, human trials in fall this year and then a regulatory filing a year later. There is basically no chance of a vaccine for this being
by technotony 6y ago
That's what the article says, human trials in fall this year and then a regulatory filing a year later. There is basically no chance of a vaccine for this being widely available before 2022. That assumes that one of these vaccines works, despite no vaccine for a coronavirus ever passing regulatory approval (hence this is a hard problem, and plenty of incentive to vaccinate against things like common cold which would be a nice money earner for a someone).
- Bombthecat 6y agoI laugh every time someone telling me we will have something by winter... We will live with quarantine and social distincing for quit for a while.
- ignoramous 6y agoWe might yet have a vaccine in 6 months (optimistically) [0] though 12 to 18 months is much more realistic. Different categories of vaccines have different manufacturing and safety profiles [1] depending on which we a vaccine candidate might be approved sooner than expected, especially since 3 novel, previously untested platforms have made it to clinical trials, already. [0] Even if shortcuts ... can be found, it is unlikely that a vaccine would be available earlier than 6 months after the initiation of clinical trials. Realistically, SARS-CoV-2 vaccines will not be available for another 12–18 months. From: https://www.cell.com/immunity/fulltext/S1074-7613(20)30120-5#%20 https://www.cell.com/immunity/fulltext/S1074-7613(20)30120-5... [1] https://www.cell.com/action/showFullTableHTML?isHtml=true&tableId=tbl1&pii=S1074-7613%2820%2930120-5 https://www.cell.com/action/showFullTableHTML?isHtml=true&ta...
- danieltillett 6y agoThere are animal vaccines for coronaviruses that have regulatory approval, just none for humans. There is zero incentive to make a vaccine for the common cold. Let me introduce you to the multi-tens of billion dollar OTC common cold treatment market.